Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/2/2025

Liver Disease and Antidepressant Therapy

Introduction to Liver Disease and Sertraline

  • The French Association for the Study of the Liver and the French Alcohol Society clinical guidelines (2022) recommend acamprosate as a safe option for patients with liver disease, as the presence of liver disease does not change the indications or conditions of acamprosate use 1
  • The French Association for the Study of the Liver and the French Alcohol Society clinical guidelines (2022) suggest baclofen can be used with caution in patients with liver disease, with a recommended gradual dose increase in severe liver disease 1

Assessment and Management of Liver Disease

  • For patients with mild liver impairment, sertraline can be considered at a reduced dose only if benefits clearly outweigh risks, according to clinical guidelines 1
  • For patients with moderate to severe liver impairment, sertraline should be avoided due to increased drug exposure and lack of safety data in this population 1
  • Acamprosate has a better safety profile in liver disease, making it a preferable alternative to sertraline, as stated by the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines (2022) 1
  • Baclofen can be used with gradual dose titration in patients with liver disease, as recommended by the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines (2022) 1

Monitoring and Precautions

  • Regular monitoring of liver function is essential if any psychotropic medication is used in patients with liver disease, to minimize the risk of hepatotoxicity and drug interactions 1
  • Patients with severe liver disease may have impaired drug metabolism leading to unpredictable drug levels, and symptoms of hepatotoxicity may be mistaken for progression of underlying liver disease, highlighting the need for close monitoring 1